Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

0ELV

Guerbet (0ELV)

Guerbet Sa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0ELV
DateTimeSourceHeadlineSymbolCompany
03/18/20245:37AMUK RegulatoryGUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 29 février 2024LSE:0ELVGuerbet Sa
02/19/202410:46AMUK RegulatoryGUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2024LSE:0ELVGuerbet Sa
12/11/202310:45AMPR Newswire (US)Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European UnionLSE:0ELVGuerbet Sa
09/21/202212:08PMPR Newswire (US)Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)LSE:0ELVGuerbet Sa
06/13/20221:30AMPR Newswire (US)Guerbet receives EMA acceptance of Elucirem™ as the Brand Name for GadopiclenolLSE:0ELVGuerbet Sa
03/07/202211:00AMPR Newswire (US)Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolizationLSE:0ELVGuerbet Sa
03/07/202211:00AMPR Newswire (US)Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolizationLSE:0ELVGuerbet Sa
 Showing the most relevant articles for your search:LSE:0ELV